245 related articles for article (PubMed ID: 33560380)
1. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
[TBL] [Abstract][Full Text] [Related]
2. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression.
Servitje O; Climent F; Colomo L; Ruiz N; García-Herrera A; Gallardo F; Mercadal S; Pomares H; Muniesa C; Martin-Callizo C; Marcoval J; Rovira R; Estrach T; Pujol RM
J Cutan Pathol; 2019 Mar; 46(3):182-189. PubMed ID: 30511443
[TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract][Full Text] [Related]
5. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.
Pham-Ledard A; Cowppli-Bony A; Doussau A; Prochazkova-Carlotti M; Laharanne E; Jouary T; Belaud-Rotureau MA; Vergier B; Merlio JP; Beylot-Barry M
Am J Clin Pathol; 2015 Mar; 143(3):362-73. PubMed ID: 25696794
[TBL] [Abstract][Full Text] [Related]
7. Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire.
Koning MT; Quinten E; Zoutman WH; Kiełbasa SM; Mei H; van Bergen CAM; Jansen P; Vergroesen RD; Willemze R; Vermeer MH; Tensen CP; Veelken H
J Invest Dermatol; 2019 Oct; 139(10):2195-2203. PubMed ID: 31042459
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
[TBL] [Abstract][Full Text] [Related]
10. Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).
Saksena A; Jain A; Pack SD; Kim J; Lee I; Tyagi M; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):409-419. PubMed ID: 36461146
[TBL] [Abstract][Full Text] [Related]
11. H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas.
Brune MM; Vela V; Bratic Hench I; Dertinger S; Borgmann V; Dirnhofer S; Tzankov A
Virchows Arch; 2022 Sep; 481(3):489-497. PubMed ID: 35661922
[TBL] [Abstract][Full Text] [Related]
12. Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma.
Bátai B; Kiss L; Varga L; Nagy Á; Househam J; Baker AM; László T; Udvari A; Horváth R; Nagy T; Csomor J; Szakonyi J; Schneider T; Graham TA; Alpár D; Fitzgibbon J; Szepesi Á; Bödör C
Mod Pathol; 2024 Mar; 37(5):100465. PubMed ID: 38460675
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation and t(14;18) in both the lymphoid and plasma cell components.
Kelley JT; Brown NA; Hristov AC; Bresler SC
J Cutan Pathol; 2021 Jul; 48(7):969-974. PubMed ID: 33786907
[TBL] [Abstract][Full Text] [Related]
15. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
Koens L; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous follicle center lymphoma in a 16-year-old girl.
Edmonds N; Hernández-Pérez M; Holsinger M; Gru AA
J Cutan Pathol; 2021 May; 48(5):663-668. PubMed ID: 33326136
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.
Dilly M; Ben-Rejeb H; Vergier B; Feldis M; Toty L; Nohra O; Beylot-Barry M; Gros A; Merlio JP; Parrens M
J Cutan Pathol; 2014 Oct; 41(10):797-801. PubMed ID: 25099172
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment.
Gulia A; Saggini A; Wiesner T; Fink-Puches R; Argenyi Z; Ferrara G; Müller CS; Vale E; Cerroni L
J Am Acad Dermatol; 2011 Nov; 65(5):991-1000. PubMed ID: 21704419
[TBL] [Abstract][Full Text] [Related]
19. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
Wilcox RA
Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
